Literature DB >> 25480781

Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload.

Hadi Javan1, Amanda M Szucsik1, Ling Li1, Christin L Schaaf1, Mohamed E Salama1, Craig H Selzman2.   

Abstract

BACKGROUND: Nuclear factor κB (NF-κB) is often implicated in contributing to the detrimental effects of cardiac injury. This ostensibly negative view of NF-κB competes with its important role in the normal host inflammatory and immune response. We have previously demonstrated that pharmacological inhibition of NF-κB at the time of acute pressure overload accelerates the progression of left ventricular hypertrophy to heart failure in mice. NF-κB regulates angiogenesis and other factors responsible for compensatory reaction to intracellular hypoxia. We hypothesized that impaired angiogenesis may be the trigger, not the result, of pathological left ventricular hypertrophy through NF-κB-related pathways. METHODS AND
RESULTS: Transgenic mice were generated with cardiomyocyte-specific deletion of the p65 subunit of NF-κB. Mice underwent transverse aortic constriction and serially followed up with echocardiography for 6 weeks. Cardiomyocyte p65 NF-κB deletion promoted maladaptive left ventricular hypertrophy and accelerated progression toward heart failure as measured by ejection fraction, left ventricular mass, and lung congestion. Transgenic mice had higher levels of fibrosis and periostin expression. Whole-field digital microscopy revealed increased capillary domain areas in knockout mice while concurrently demonstrating decreased microvessel density. This observation was associated with decreased expression of hypoxia-inducible factor 1α.
CONCLUSIONS: Rather than developing compensatory left ventricular hypertrophy, pressure overload in cardiomyocyte NF-κB-deficient mice resulted in functional deterioration that was associated with increased fibrosis, decreased hypoxia-inducible factor expression, and decreased microvessel density. These observations mechanistically implicate NF-κB, and its regulation of hypoxic stress, as an important factor determining the path between adaptive hypertrophy and maladaptive heart failure.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  NF-κB; heart decompensation; hypoxia-inducible factor 1; microcirculation

Mesh:

Substances:

Year:  2014        PMID: 25480781      PMCID: PMC4303522          DOI: 10.1161/CIRCHEARTFAILURE.114.001297

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  48 in total

1.  Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy?

Authors:  Nicole H Purcell; Jeffery D Molkentin
Journal:  Circulation       Date:  2003-08-12       Impact factor: 29.690

Review 2.  Tissue capillary supply--it's quality not quantity that counts!

Authors:  Stuart Egginton; Eamonn Gaffney
Journal:  Exp Physiol       Date:  2010-07-21       Impact factor: 2.969

3.  Role of the NF-kappaB signaling cascade and NF-kappaB-targeted genes in failing human hearts.

Authors:  Sudhiranjan Gupta; Subha Sen
Journal:  J Mol Med (Berl)       Date:  2005-08-17       Impact factor: 4.599

4.  Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.

Authors:  Tariq Hamid; Shang Z Guo; Justin R Kingery; Xilin Xiang; Buddhadeb Dawn; Sumanth D Prabhu
Journal:  Cardiovasc Res       Date:  2010-08-25       Impact factor: 10.787

Review 5.  Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure.

Authors:  Guro Valen
Journal:  Basic Res Cardiol       Date:  2003-10-30       Impact factor: 17.165

6.  Myocardin inhibits cellular proliferation by inhibiting NF-kappaB(p65)-dependent cell cycle progression.

Authors:  Ru-Hang Tang; Xi-Long Zheng; Thomas E Callis; William E Stansfield; Jiayin He; Albert S Baldwin; Da-Zhi Wang; Craig H Selzman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

Review 7.  Pathological ventricular remodeling: mechanisms: part 1 of 2.

Authors:  Jana S Burchfield; Min Xie; Joseph A Hill
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

8.  Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.

Authors:  Sudhiranjan Gupta; David Young; Ratan K Maitra; Anasuya Gupta; Zoran B Popovic; Sandro L Yong; Anjuli Mahajan; Qing Wang; Subha Sen
Journal:  J Mol Biol       Date:  2007-10-10       Impact factor: 5.469

9.  The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression.

Authors:  Shungo Hikoso; Osamu Yamaguchi; Yuko Nakano; Toshihiro Takeda; Shigemiki Omiya; Isamu Mizote; Manabu Taneike; Takafumi Oka; Takahito Tamai; Jota Oyabu; Yoshihiro Uno; Yasushi Matsumura; Kazuhiko Nishida; Keiichiro Suzuki; Mikihiko Kogo; Masatsugu Hori; Kinya Otsu
Journal:  Circ Res       Date:  2009-05-28       Impact factor: 17.367

10.  A20 is dynamically regulated in the heart and inhibits the hypertrophic response.

Authors:  Stuart A Cook; Mikhail S Novikov; Youngkeun Ahn; Takashi Matsui; Anthony Rosenzweig
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

View more
  9 in total

1.  S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.

Authors:  Ana Paula Cremasco Takano; Carolina Demarchi Munhoz; Anselmo Sigari Moriscot; Sudhiranjan Gupta; Maria Luiza Morais Barreto-Chaves
Journal:  J Mol Med (Berl)       Date:  2017-02-04       Impact factor: 4.599

2.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Authors:  Tim Lahm; Ivor S Douglas; Stephen L Archer; Harm J Bogaard; Naomi C Chesler; Francois Haddad; Anna R Hemnes; Steven M Kawut; Jeffrey A Kline; Todd M Kolb; Stephen C Mathai; Olaf Mercier; Evangelos D Michelakis; Robert Naeije; Rubin M Tuder; Corey E Ventetuolo; Antoine Vieillard-Baron; Norbert F Voelkel; Anton Vonk-Noordegraaf; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

3.  Smad Nuclear Interacting Protein 1 Acts as a Protective Regulator of Pressure Overload-Induced Pathological Cardiac Hypertrophy.

Authors:  Yu-Yan Lu; Da-Chun Xu; Yi-Fan Zhao; Guo-Fu Zhu; Meng-Yun Zhu; Wei-Jing Liu; Xue-Jing Yu; Wei Chen; Zheng Liu; Ya-Wei Xu
Journal:  J Am Heart Assoc       Date:  2016-10-26       Impact factor: 5.501

4.  Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model.

Authors:  Bo Zhang; Dan Wang; Tie-Feng Ji; Lei Shi; Jin-Lu Yu
Journal:  Oncotarget       Date:  2017-03-07

Review 5.  Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.

Authors:  Akylbek Sydykov; Argen Mamazhakypov; Aleksandar Petrovic; Djuro Kosanovic; Akpay S Sarybaev; Norbert Weissmann; Hossein A Ghofrani; Ralph T Schermuly
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

6.  Osthole attenuates angiogenesis in an orthotopic mouse model of hepatocellular carcinoma via the downregulation of nuclear factor-κB and vascular endothelial growth factor.

Authors:  Fei Yao; Lurong Zhang; Guorong Jiang; Min Liu; Guoqiang Liang; Qin Yuan
Journal:  Oncol Lett       Date:  2018-07-25       Impact factor: 2.967

7.  The Modulation of Nrf-2/HO-1 Signaling Axis by Carthamus tinctorius L. Alleviates Vascular Inflammation in Human Umbilical Vein Endothelial Cells.

Authors:  Yun Jung Lee; Yong Pyo Lee; Chang Seob Seo; Eun Sik Choi; Byung Hyuk Han; Jung Joo Yoon; Se Hoon Jang; Chae Ghang Jeong; Yeun Ja Mun; Dae Gill Kang; Ho Sub Lee
Journal:  Plants (Basel)       Date:  2021-12-17

8.  Positive effect of Periostin on repair of Isopreternol induced ischemic damaged cardiomyocyte: an in vitro model.

Authors:  Saeideh Edalati; Safoura Khajeniazi
Journal:  Regen Ther       Date:  2022-03-19       Impact factor: 3.419

9.  Histone Acetyltransferase p300 Inhibitor Improves Coronary Flow Reserve in SIRT3 (Sirtuin 3) Knockout Mice.

Authors:  Han Su; Heng Zeng; Xiaochen He; Shai-Hong Zhu; Jian-Xiong Chen
Journal:  J Am Heart Assoc       Date:  2020-08-31       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.